153 related articles for article (PubMed ID: 32861252)
1. Utility of the Aortic-Lesion-Attenuation-Difference (ALAD) and Peak Early-Phase Enhancement Ratio (PEER) to differentiate benign from malignant renal masses.
Kahn AE; Lomax SJ; Bajalia EM; Ball CT; Thiel DD
Can J Urol; 2020 Aug; 27(4):10278-10284. PubMed ID: 32861252
[TBL] [Abstract][Full Text] [Related]
2. Using Aorta-Lesion-Attenuation Difference on Preoperative Contrast-enhanced Computed Tomography Scan to Differentiate Between Malignant and Benign Renal Tumors.
Grajo JR; Terry RS; Ruoss J; Noennig BJ; Pavlinec JG; Bozorgmehri S; Crispen PL; Su LM
Urology; 2019 Mar; 125():123-130. PubMed ID: 30552939
[TBL] [Abstract][Full Text] [Related]
3. Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms.
Dhyani M; Grajo JR; Rodriguez D; Chen Z; Feldman A; Tambouret R; Gervais DA; Arellano RS; Hahn PF; Samir AE
Abdom Radiol (NY); 2017 Jun; 42(6):1734-1743. PubMed ID: 28197683
[TBL] [Abstract][Full Text] [Related]
4. Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT.
Gentili F; Bronico I; Maestroni U; Ziglioli F; Silini EM; Buti S; de Filippo M
Radiol Med; 2020 Dec; 125(12):1280-1287. PubMed ID: 32385827
[TBL] [Abstract][Full Text] [Related]
5. Validation of aorta-lesion-attenuation difference on preoperative contrast-enhanced computed tomography scan to differentiate between malignant and benign oncocytic renal tumors.
Grajo JR; Batra NV; Bozorgmehri S; Magnelli LL; Pavlinec J; O'Malley P; Su LM; Crispen PL
Abdom Radiol (NY); 2021 Jul; 46(7):3269-3279. PubMed ID: 33665734
[TBL] [Abstract][Full Text] [Related]
6. Association between nuclear grade of renal cell carcinoma and the aorta-lesion-attenuation-difference.
Grajo JR; Batra NV; Bozorgmehri S; Magnelli LL; O'Malley P; Terry R; Su LM; Crispen PL
Abdom Radiol (NY); 2021 Dec; 46(12):5629-5638. PubMed ID: 34463815
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment differentiation of renal cell carcinoma subtypes by CT: the influence of different tumor enhancement measurement approaches.
Zokalj I; Marotti M; Kolarić B
Int Urol Nephrol; 2014 Jun; 46(6):1089-100. PubMed ID: 24381132
[TBL] [Abstract][Full Text] [Related]
8. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
[TBL] [Abstract][Full Text] [Related]
9. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography.
Bird VG; Kanagarajah P; Morillo G; Caruso DJ; Ayyathurai R; Leveillee R; Jorda M
World J Urol; 2011 Dec; 29(6):787-92. PubMed ID: 20717829
[TBL] [Abstract][Full Text] [Related]
11. Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma.
Pierorazio PM; Hyams ES; Tsai S; Feng Z; Trock BJ; Mullins JK; Johnson PT; Fishman EK; Allaf ME
Urology; 2013 Jun; 81(6):1265-71. PubMed ID: 23601445
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of renal oncocytoma and renal clear cell carcinoma using relative CT enhancement ratio.
Ren A; Cai F; Shang YN; Ma ES; Huang ZG; Wang W; Lu Y; Zhang XZ
Chin Med J (Engl); 2015 Jan; 128(2):175-9. PubMed ID: 25591558
[TBL] [Abstract][Full Text] [Related]
13. Subtype differentiation of small renal cell carcinomas on three-phase MDCT: usefulness of the measurement of degree and heterogeneity of enhancement.
Jung SC; Cho JY; Kim SH
Acta Radiol; 2012 Feb; 53(1):112-8. PubMed ID: 22114020
[TBL] [Abstract][Full Text] [Related]
14. Segmental enhancement inversion at biphasic multidetector CT: characteristic finding of small renal oncocytoma.
Kim JI; Cho JY; Moon KC; Lee HJ; Kim SH
Radiology; 2009 Aug; 252(2):441-8. PubMed ID: 19508984
[TBL] [Abstract][Full Text] [Related]
15. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
[TBL] [Abstract][Full Text] [Related]
16. Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT.
Sasaguri K; Takahashi N; Gomez-Cardona D; Leng S; Schmit GD; Carter RE; Leibovich BC; Kawashima A
AJR Am J Roentgenol; 2015 Nov; 205(5):999-1007. PubMed ID: 26496547
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT.
Kim SH; Kim CS; Kim MJ; Cho JY; Cho SH
AJR Am J Roentgenol; 2016 Jan; 206(1):W21-8. PubMed ID: 26700359
[TBL] [Abstract][Full Text] [Related]
18. Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses.
Lee-Felker SA; Felker ER; Tan N; Margolis DJ; Young JR; Sayre J; Raman SS
AJR Am J Roentgenol; 2014 Nov; 203(5):W516-24. PubMed ID: 25341166
[TBL] [Abstract][Full Text] [Related]
19. Effect of phase of enhancement on texture analysis in renal masses evaluated with non-contrast-enhanced, corticomedullary, and nephrographic phase-enhanced CT images.
Nguyen K; Schieda N; James N; McInnes MDF; Wu M; Thornhill RE
Eur Radiol; 2021 Mar; 31(3):1676-1686. PubMed ID: 32914197
[TBL] [Abstract][Full Text] [Related]
20. Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis.
Jinzaki M; Tanimoto A; Mukai M; Ikeda E; Kobayashi S; Yuasa Y; Narimatsu Y; Murai M
J Comput Assist Tomogr; 2000; 24(6):835-42. PubMed ID: 11105696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
